Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Mahidol University's Institutional Repository (Mahidol IR)
Simple jQuery Dropdowns
About Us
Ethics
Service
Statistics & Reports
Feedback
Browsing by Author Neil Gallagher
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 2 of 2
Issue Date
Title
Author(s)
1-Jan-2012
Expanding Nilotinib Access in Clinical Trials (ENACT): An open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase
Franck E. Nicolini
;
Anna Turkina
;
Zhi Xiang Shen
;
Neil Gallagher
;
Saengsuree Jootar
;
Bayard L. Powell
;
Carmino De Souza
;
Ming Zheng
;
Tomasz Szczudlo
;
Philipp Le Coutre
;
Hopital Edouard Herriot
;
National Research Center for Hematology
;
Ruijin Hospital
;
Novartis International AG
;
Mahidol University
;
Wake Forest University Baptist Medical Center
;
Universidade Estadual de Campinas
;
Novartis Pharmaceuticals Corporation
;
Charité – Universitätsmedizin Berlin
17-Jun-2010
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
Giuseppe Saglio
;
Dong Wook Kim
;
Surapol Issaragrisil
;
Philipp Le Coutre
;
Gabriel Etienne
;
Clarisse Lobo
;
Ricardo Pasquini
;
Richard E. Clark
;
Andreas Hochhaus
;
Timothy P. Hughes
;
Neil Gallagher
;
Albert Hoenekopp
;
Mei Dong
;
Ariful Haque
;
Richard A. Larson
;
Hagop M. Kantarjian
;
Universita degli Studi di Torino
;
The Catholic University of Korea
;
Mahidol University
;
Charité – Universitätsmedizin Berlin
;
Institut Bergonie
;
Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti
;
Universidade Federal do Parana
;
Royal Liverpool and Broadgreen University Hospitals NHS Trust
;
Universitatsklinikum Jena und Medizinische Fakultat
;
Royal Adelaide Hospital
;
Novartis International AG
;
Novartis Pharmaceuticals
;
University of Chicago
;
University of Texas MD Anderson Cancer Center